Abstract
Colorectal cancer (CRC) is a prevalent gastrointestinal cancer posing significant clinical challenges. CRC management traditionally involves surgery, often coupled with chemotherapy. However, unresectable or metastatic CRC (mCRC) presents a complex challenge necessitating innovative treatment strategies. Targeted therapies have emerged as the cornerstone of treatment in such cases, with interventions tailored to specific molecular attributes. Concurrently, immunotherapies have revolutionized cancer treatment by harnessing the immune system to combat malignant cells. This review explores the evolving landscape of CRC treatment, focusing on the synergy between immunotherapies and targeted therapies, thereby offering new avenues for enhancing the effectiveness of therapy for CRC.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 598-609 |
| Number of pages | 12 |
| Journal | Trends in Cancer |
| Volume | 10 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2024 |
Keywords
- colorectal cancer (CRC)
- immune checkpoint inhibitors
- immunotherapies
- targeted therapies
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Advancements in combining targeted therapy and immunotherapy for colorectal cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS